Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Lipella Pharms Inc (LIPO)

Lipella Pharms Inc (LIPO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Lipella Pharms Inc 7800 SUSQUEHANNA STREET SUITE 505 PITTSBURGH PA 15208 USA

www.lipella.com Employees: 7 P: 412-894-1853

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Lipella Pharmaceuticals Inc. is a clinical-stage biotechnology company. It focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. Lipella Pharmaceuticals Inc. is based in PITTSBURGH.

Key Statistics

Overview:

Market Capitalization, $K 717
Enterprise Value, $K -1,463
Shares Outstanding, K 4,621
Float, K 3,137
% Float 67.89%
Short Interest, K 3
Short Float 0.06%
Days to Cover 1.00
Short Volume Ratio 0.00
% of Insider Shareholders 32.11%
% of Institutional Shareholders 74.31%

Financials:

Annual Sales, $ 540 K
Annual Net Income, $ -5,020 K
Last Quarter Sales, $ 90 K
Last Quarter Net Income, $ -1,330 K
EBIT, $ -5,600 K
EBITDA, $ -5,600 K

Growth:

1-Year Return -95.69%
3-Year Return -99.08%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.28 on 11/14/25
Next Earnings Date 03/26/26
Earnings Per Share ttm -3.43
EPS Growth vs. Prev Qtr 9.68%
EPS Growth vs. Prev Year 78.29%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-8 on 11/08/24

LIPO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -208.45%
Return-on-Assets % -156.76%
Profit Margin % -929.63%
Debt/Equity 0.00
Price/Sales 5.87
Price/Cash Flow N/A
Price/Book 0.60
Book Value/Share 0.61
Interest Coverage -1.51
60-Month Beta 0.08
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar